CAY10568

CAY10568
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T37670-10mg 10 mg -

7 - 10 business days*

91.00€
TGM-T37670-25mg 25 mg -

7 - 10 business days*

210.00€
TGM-T37670-50mg 50 mg -

7 - 10 business days*

385.00€
TGM-T37670-100mg 100 mg -

7 - 10 business days*

679.00€
 
Description: Most local anesthetics act by abolishing voltage gated sodium channel currents... more
Product information "CAY10568"
Description: Most local anesthetics act by abolishing voltage gated sodium channel currents indiscriminately in all populations of neurons. Selective analgesia through TRPV1-mediated entry of a cationic lidocaine derivative, QX314, was recently reported. CAY10568 is a physically smaller, less hydrophobic version of QX314 designed to be even more permeable to TRPV1 ion channel when activated by agonists such as capsaicin and N-oleoyl dopamine. CAY10568 when given in combination with suitable TRPV1 agonists should produce selective blockade of the pain response while leaving motor, touch, and proprioception intact. Target: Others. Smiles: [I-].C[N+](C)(C)CC(=O)Nc1ccccc1
Supplier: TargetMol
Supplier-Nr: T37670

Properties

Application: Metabolic studies
MW: 320.174 D
Formula: C11H17IN2O

Database Information

CAS : 22913-17-3| Matching products
KEGG ID : K05222 | Matching products

Handling & Safety

Storage: +4°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "CAY10568"
Write a review
or to review a product.
Viewed